Drugs / Intermediate acting insulin
last change Jan 2016 re-read 2 minutes ago

Intermediate acting insulin

Developed for
hyperglycemia
Investigated by
Slotervaart Hospital

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02155374 May 2014 → Dec 2015 hyperglycemia Slotervaart Hospital Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Intermediate acting insulin ClinicalTrials.gov intervention name — accepted as the source's own label NCT02155374
Route Subcutaneous “once daily subcutaneousNCT02155374